Abstract
Mycophenolic acid (MPA) was identified as an inhibitor of syncytium formation during the screening of human immunodeficiency virus (HIV) entry inhibitors. MPA is a well-known inhibitor of inosine monophosphate dehydrogenase and anti-HIV activity has been reported in vitro and in vivo. MPA inhibited syncytium formation in T cell-tropic and macrophage-tropic systems with IC50 values of 0.1 and 0.5 µM, respectively. The reduction of HIV gp120 expression by MPA (1.0 µM) was observed by use of Western blot analysis. Furthermore, the addition of guanosine restored both syncytium formation and gp120 expression in the presence of MPA. These results suggest that MPA inhibits not only reverse transcription by depletion of a substrate, GTP, as has been reported, but also syncytium formation through a predominant reduction in the amount of gp120 that is vigorously expressed in the above transformed cells and may be in HIV-infected cells.
Similar content being viewed by others
Article PDF
References
Chiba H, Asanuma S, Okamoto M, Inokoshi J, Tanaka H, Fujita K, Ōmura S . A simple screening system for anti-HIV drugs: syncytium formation assay using T-cell line tropic and macrophage tropic HIV env expressing cell lines—establishment and validation. J Antibiot 54: 818–826 ( 2001)
Halloran P, Mathew T, Tomlanovich S, Groth C, Hooftman L, Baker C . Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized double-blind, clinical studied in prevention of rejection. Transplantation 63: 39–47 ( 1997)
Allison AC, Eugai EM . Mycophenolate mofetil and its mechanisms of action. Immunopharmacology 47: 85–118 ( 2000)
Weigel G, Griesmacher A, Zuckermann AO, Laufer G, Mueller MM . Effect of mycophenolate mofetil therapy on inosine monophosphate dehydrogenase induction in red blood cells of heart transplant recipients. Clin Pharmacol Ther 69: 137–144 ( 2001)
Ichimura H, Levy JA . Polymerase substrate depletion: A novel strategy for inhibiting the replication of the human immunodeficiency virus. Virology 211: 554–560 ( 1995)
Chapuis AG, Rizzardi GP, D'Agostino C, Attinger A, Knabenhans C, Fleury S, Acha-Orbea H, Pantaleo G . Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 6: 762–768 ( 2000)
Margolis D, Heredia A, Gaywee J, Oldach D, Drusano G, Redfield R . Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity. J Acquir Immune Defic Syndr 21: 362–370 ( 1999)
Hossain MM, Coull JJ, Drusano GL, Margolis DM . Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. Antiviral Res 55: 41–52 ( 2002)
Margolis DM, Kewn S, Coull JJ, Ylisastigui L, Turner D, Wise H, Hossain MM, Lanier ER, Shaw LM, Back D . The addition of mycophenolate mofetil to antiretroviral therapy including abacavir is associated with depletion of intracellular deoxyguanosine triphosphate and a decrease in plasma HIV-1 RNA. J Acquir Immune Defic Syndr 31: 45–49 ( 2002)
Mosmann T . Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65: 55–63 ( 1983)
Sokoloski JA, Sartorelli AC . Effects of the inhibitors of IMP dehydrogenase, tiazofurin and mycophenolic acid, on glycoprotein metabolism. Mol Pharmacol 28: 567–573 ( 1985)
Sokoloski JA, Blair OC, Sartorelli AC . Alterations in glycoprotein synthesis and guanosine triphosphate levels associated with the differentiation of HL-60 leukemia cells produced by inhibitors of inosine 5′-phosphate dehydrogenase. Cancer Res 46: 2314–2319 ( 1986)
Laurent AF, Dumont S, Poindron P, Muller CD . Mycophenolic acid suppresses protein N-linked glycosylation in human monocytes and their adhesion to endotherial cells and to some substrates. Exp Hematol 24: 59–67 ( 1996)
Williams RH, Lively DH, DeLong DC, Cline JC, Sweeney MJ, Poore GA, Larsen SH . Mycophenolic acid: antiviral and antitumor properties. J Antibiot 21: 463–464 ( 1968)
Carter SB, Franklin TJ, Jones DF, Leonard BJ, Mills SD, Turner RW, Turner WB . Mycophenolic acid: an anti-cancer compound with unusual properties. Nature 223: 848–850 ( 1969)
Suzuki S, Kimura T, Ando K, Sawada M, Tamura G . Antitumor activity of mycophenolic acid. J Antibiot 22: 297–302 ( 1969)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ui, H., Asanuma, S., Chiba, H. et al. Mycophenolic Acid Inhibits Syncytium Formation Accompanied by Reduction of gp120 Expression. J Antibiot 58, 514–518 (2005). https://doi.org/10.1038/ja.2005.69
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ja.2005.69
Keywords
This article is cited by
-
Two new members of mycophenolic acid family from Penicillium brevicompactum Dierckx
The Journal of Antibiotics (2009)